U.S. markets open in 8 hours 41 minutes

Verastem, Inc. (VSTM)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
12.70+0.66 (+5.48%)
At close: 04:00PM EST
12.30 -0.40 (-3.15%)
After hours: 08:00PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close12.04
Bid0.00 x 1000
Ask0.00 x 800
Day's Range12.05 - 13.25
52 Week Range4.20 - 15.12
Avg. Volume117,000
Market Cap320.905M
Beta (5Y Monthly)0.47
PE Ratio (TTM)N/A
EPS (TTM)-3.89
Earnings DateMar 12, 2024 - Mar 18, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est28.79
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value

Subscribe to Yahoo Finance Plus to view Fair Value for VSTM

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Verastem, Inc.
    Analyst Report: AbbVie Inc.AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
    Fair Value
    Economic Moat
    6 days agoMorningstar
View more

    Andreas Halvorsen's Viking Global Investors LP Bolsters Position in Verastem Inc

    The transaction, which took place on December 31, 2023, involved the acquisition of 75,537 shares at a trade price of $8.14 per share. This strategic move has expanded Viking Global's holding to a total of 2,531,829 shares in Verastem Inc, reflecting the firm's confidence in the company's future prospects.


    Director Robert Gagnon Sells 9,204 Shares of Verastem Inc (VSTM)

    On February 6, 2024, Robert Gagnon, a director at Verastem Inc, executed a sale of 9,204 shares of the company.

  • InvestorPlace

    3 Stocks That AI Predicts Will Deliver Triple-Digit Returns This Year: February 2024

    In the vast landscape of today’s markets, artificial intelligence (AI) is reshaping investment strategies. Therefore, AI stock picks are as relevant as ever. AI’s ability to analyze extensive datasets and discern patterns gives it a unique edge. In essence, it makes it an incredibly valuable research tool. Recently, I harnessed the prowess of Chat-GPT to generate some fresh stock ideas for 2024 that could deliver triple-digit returns. My first prompt was the following: “Kindly conduct an in-dept